The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Survivin: A promising tumor biomarker
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
Ambrosini, G., Adida, C., & Altieri, D. C. (1997) · Nature Medicine · doi:10.1038/nm0897-917 · Cited by 3,165
IAP family proteins---suppressors of apoptosis
Deveraux, Q. L., & Reed, J. C. (1999) · Genes & Development · doi:10.1101/gad.13.3.239 · Cited by 2,551
Johnstone (2002) · doi:10.1016/s0092-8674(02)00625-6 · Cited by 1,876
Control of apoptosis and mitotic spindle checkpoint by survivin
Li, F., Ambrosini, G., Chu, E. Y., Plescia, J., Tognin, S., Marchisio, P. C., & Altieri, D. C. (1998) · Nature · doi:10.1038/25141 · Cited by 1,870
Tamm, I., Wang, Y., Sausville, E. A., Scudiero, D. A., Vigna, N. J., Oltersdorf, T., & Reed, J. C. (1998) · PubMed · Cited by 1,244
Validating survivin as a cancer therapeutic target
Altieri, D. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc968 · Cited by 1,206
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
Singletary, S. E., Allred, C., Ashley, P., Bassett, L. W., Berry, D., Bland, K. I., Borgen, P. I., Clark, G., Edge, S. B., Hayes, D. F., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.02.026 · Cited by 1,173
Pathways of apoptotic and non-apoptotic death in tumour cells
Okada, H., & Mak, T. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1412 · Cited by 1,044
Survivin, versatile modulation of cell division and apoptosis in cancer
Altieri, D. C. (2003) · Oncogene · doi:10.1038/sj.onc.1207113 · Cited by 900
Carcinoembryonic Antigen as a Marker for Colorectal Cancer: Is It Clinically Useful?
Duffy, M. J. (2001) · Clinical Chemistry · doi:10.1093/clinchem/47.4.624 · Cited by 794
Self-citationAnalysis of human transcriptomes
Velculescu, V. E., Madden, S. L., Zhang, L., Lash, A. E., Yu, J., Rago, C., Lal, A., Wang, C. J., Beaudry, G. A., Ciriello, K. M., et al. (1999) · Nature Genetics · doi:10.1038/70487 · Cited by 774
Structural basis for phosphoserine-proline recognition by group IV WW domains.
Verdecia, M. A., Bowman, M. E., Lu, K. P., Hunter, T. R., & Noel, J. P. (2000) · Nature Structural Biology · doi:10.1038/77929 · Cited by 704
An Anti-apoptotic Protein Human Survivin Is a Direct Inhibitor of Caspase-3 and -7
Shin, S., Sung, B.-J., Cho, Y.-S., Kim, H.-J., Ha, N.-C., Hwang, J.-I., Chung, C.-W., Jung, Y.-K., & Oh, B.-H. (2001) · Biochemistry · doi:10.1021/bi001603q · Cited by 674
Pleiotropic cell-division defects and apoptosis induced by interference with survivin function
Li, F., Ackermann, E. J., Bennett, C. F., Rothermel, A. L., Plescia, J., Tognin, S., Villa, A., Marchisio, P. C., & Altieri, D. C. (1999) · Nature Cell Biology · doi:10.1038/70242 · Cited by 600
Uren, A. G., Wong, L., Pakusch, M., Fowler, K. J., Burrows, F. J., Vaux, D. L., & Choo, K. H. A. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00769-7 · Cited by 527
Detection and Clinical Importance of Micrometastatic Disease
Pantel, K., Cote, R. J., & Fodstad, O. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.13.1113 · Cited by 493
Olie, R. A., Simões‐Wüst, A. P., Baumann, B., Leech, S. H., Fabbro, D., Stahel, R. A., & Zangemeister‐Wittke, U. (2000) · PubMed · Cited by 489
Monzó, M., Rosell, R., Felip, E., Astudillo, J., Sánchez, J. J., Maestre, J., Martín, C., Font, A., Barnadas, A., & Abad, A. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2100 · Cited by 487
A role for survivin in chemoresistance of endothelial cells mediated by VEGF
Tran, J., Master, Z., Yu, J. L., Rak, J., Dumont, D. J., & Kerbel, R. S. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072586399 · Cited by 434
HBXIP functions as a cofactor of survivin in apoptosis suppression
Marusawa, H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg263 · Cited by 432
Anti-apoptosis gene, survivin, and prognosis of neuroblastoma
Adida, C., Berrebi, D., Peuchmaur, M., Reyes-Mugica, M., & Altieri, D. C. (1998) · The Lancet · doi:10.1016/s0140-6736(05)70294-4 · Cited by 415
Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis
Dohi, T., Beltrami, E., Wall, N. R., Plescia, J., & Altieri, D. C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422222 · Cited by 405
An IAP-IAP Complex Inhibits Apoptosis
Dohi, T., Okada, K., Xia, F., Wilford, C. E., Samuel, T., Welsh, K., Marusawa, H., Zou, H., Armstrong, R., Matsuzawa, S.-I., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400236200 · Cited by 398
Song, Z., Yao, X., & Wu, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300957200 · Cited by 363
Prognostic significance of survivin expression in diffuse large B-cell lymphomas.
Adida, C., Haïoun, C., Gaulard, P., Lepage, É., Morel, P., Brière, J., Dombret, H., Reyes, F., Diebold, J., Gisselbrecht, C., et al. (2000) · PubMed · doi:10.1182/blood.v96.5.1921 · Cited by 359
Kato, J., Kuwabara, Y., Mitani, M., Shinoda, N., Sato, A., Toyama, T., Mitsui, A., Nishiwaki, T., Moriyama, S., Kudo, J., et al. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010320)95:2<92::aid-ijc1016>3.0.co;2-9 · Cited by 345
Control of Apoptosis during Angiogenesis by Survivin Expression in Endothelial Cells
O'Connor, D. S., Schechner, J. S., Adida, C., Mesri, M., Rothermel, A. L., Li, F., Nath, A. K., Pober, J. S., & Altieri, D. C. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64742-6 · Cited by 341
Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement.
Noel, J. P., Verdecia, M. A., Huang, H.-K., Sonnenburg, E. D., Kaiser, D. A., & Hunter, T. R. (2000) · Nature Structural Biology · doi:10.1038/76838 · Cited by 337
Cancer gene therapy using a survivin mutant adenovirus
Mesri, M., Wall, N. R., Li, J., Kim, R. W., & Altieri, D. C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12983 · Cited by 337
Tran, J., Rak, J., Sheehan, C., Saibil, S. D., LaCasse, E., Korneluk, R. G., & Kerbel, R. S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1589 · Cited by 333
Expression of the antiapoptosis gene, Survivin, predicts death from recurrent colorectal carcinoma
Sarela, A. I. (2000) · Gut · doi:10.1136/gut.46.5.645 · Cited by 323
Survivin study: What is the next wave?
Li, F. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10327 · Cited by 309
Fortugno, P., Wall, N. R., Giodini, A., O'Connor, D. S., Plescia, J., Padgett, K. M., Tognin, S., Marchisio, P. C., & Altieri, D. C. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.3.575 · Cited by 307
Tumor Content of the Antiapoptosis Molecule Survivin and Recurrence of Bladder Cancer
Swana, H. S., Grossman, D., Anthony, J. N., Weiss, R. M., & Altieri, D. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410614 · Cited by 301
Rödel, F., Hoffmann, J., Distel, L., Herrmann, M., Noisternig, T., Papadopoulos, T., Sauer, R., & Rödel, C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3028 · Cited by 292
Inhibition of melanoma tumor growth in vivo by survivin targeting
Grossman, D., Kim, P. J., Schechner, J. S., & Altieri, D. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.635 · Cited by 286
Kawasaki, H., Toyoda, M., Shinohara, H., Okuda, J., Watanabe, I., Yamamoto, T., Tanaka, K., Tenjo, T., & Tanigawa, N. (2001) · Cancer · doi:10.1002/1097-0142(20010601)91:11<2026::aid-cncr1228>3.0.co;2-e · Cited by 279
Quantitatively Determined Survivin Expression Levels Are of Prognostic Value in Human Gliomas
Chakravarti, A., Noll, E., Black, P. M., Finkelstein, D., Finkelstein, D. M., Dyson, N. J., & Loeffler, J. S. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.4.1063 · Cited by 278
Zaffaroni, N., Pennati, M., Colella, G., Perego, P., Supino, R., Gatti, L., Pilotti, S., Zunino, F., & Daidone, M. G. (2002) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-002-8518-3 · Cited by 275
Elevated expression of inhibitor of apoptosis proteins in prostate cancer.
Krajewska, M., Krajewski, S., Banares, S., Huang, X., Turner, B., Bubendorf, L., Kallioniemi, O., Shabaik, A. S., Vitiello, A., Peehl, D. M., et al. (2003) · PubMed · Cited by 275
Satoh, K., Kaneko, K., Hirota, M., Masamune, A., Satoh, A., & Shimosegawa, T. (2001) · Cancer · doi:10.1002/1097-0142(20010715)92:2<271::aid-cncr1319>3.0.co;2-0 · Cited by 256
Regulation of microtubule stability and mitotic progression by survivin.
Giodini, A., Kallio, M. J., Wall, N. R., Gorbsky, G. J., Tognin, S., Marchisio, P. C., Symons, M. H., & Altieri, D. C. (2002) · PubMed · Cited by 256
Fraser, A. G., James, C., Evan, G. I., & Hengartner, M. O. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80137-7 · Cited by 222
Blanc‐Brude, O., Mesri, M., Wall, N. R., Plescia, J., Dohi, T., & Altieri, D. C. (2003) · PubMed · Cited by 210
Williams, N. S., Gaynor, R. B., Scoggin, S. O., Verma, U. N., Gokaslan, T., Simmang, C. L., Fleming, J. B., Tavana, D., Frenkel, E. P., & Becerra, C. R. (2003) · PubMed · Cited by 209
Grossman, D., Kim, P. J., Blanc-Brude, O. P., Brash, D. E., Tognin, S., Marchisio, P. C., & Altieri, D. C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13345 · Cited by 206
Survivin as a Radioresistance Factor in Pancreatic Cancer
Asanuma, K., Moriai, R., Yajima, T., Yagihashi, A., Yamada, M., Kobayashi, D., & Watanabe, N. (2000) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2000.tb00906.x · Cited by 205
Survivin splice variants regulate the balance between proliferation and cell death
Caldas, H., Jiang, Y., Holloway, M. P., Fangusaro, J., Mahotka, C., Conway, E. M., & Altura, R. A. (2005) · Oncogene · doi:10.1038/sj.onc.1208350 · Cited by 199
Survivin mediates targeting of the chromosomal passenger complex to the centromere and midbody
Vader, G., Kauw, J. J. W., Medema, R. H., & Lens, S. M. A. (2006) · EMBO reports · doi:10.1038/sj.embor.7400562 · Cited by 195
Role for yeast inhibitor of apoptosis (IAP)-like proteins in cell division
Uren, A. G., Beilharz, T., O’Connell, M. J., Bugg, S. J., van Driel, R., Vaux, D. L., & Lithgow, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10170 · Cited by 192
Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa
Gianani, R., Jarboe, E., Orlicky, D., Frost, M., Bobak, J., Lehner, R., & Shroyer, K. R. (2001) · Human Pathology · doi:10.1053/hupa.2001.21897 · Cited by 181
Cell division and cell survival in the absence of survivin
Yang, D., Welm, A., & Bishop, J. M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406665101 · Cited by 177
Ling, X., Bernacki, R. J., Brattain, M. G., & Li, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310947200 · Cited by 175
Effects of Survivin Antagonists on Growth of Established Tumors and B7-1 Immunogene Therapy
Kanwar, J. R., Shen, W.-P., Kanwar, R. K., Berg, R. W., & Krissansen, G. W. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.20.1541 · Cited by 172
Tu, S. P., JIANG, X. H., Lin, M. C. M., Cui, J. T., Yang, Y., Lum, C. T., Zou, B., Zhu, Y. B., Jiang, S. H., Wong, W. M., et al. (2003) · PubMed · Cited by 167
Differential subcellular localization of functionally divergent survivin splice variants
Mahotka, C., Liebmann, J., Wenzel, M., et al. (2002) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401091 · Cited by 162
Clinical Uses of Tumor Markers: A Critical Review
Duffy, M. J. (2001) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/20014091084218 · Cited by 161
Self-citationPrognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma
Grabowski, P., Kühnel, T., Mühr-Wilkenshoff, F., Heine, B., Stein, H., Höpfner, M., Germer, C. T., & Scherübl, H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600696 · Cited by 158
Ryan, B. M., Konecny, G. E., Kahlert, S., Wang, H.-J., Untch, M., Meng, G., Pegram, M. D., Podratz, K. C., Crown, J., Slamon, D. J., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdj121 · Cited by 158
Self-citationIdentification of a novel splice variant of the human anti-apoptopsis gene survivin
Badran, A., Yoshida, A., Ishikawa, K., Goi, T., Yamaguchi, A., Ueda, T., & Inuzuka, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.178 · Cited by 150
Rödel, C. M., Haas, J., Groth, A., Grabenbauer, G. G., Sauer, R., & Rödel, F. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04618-7 · Cited by 146
Krieg, A. H., Mahotka, C., Krieg, T. M., Grabsch, H. I., Müller, W., Takeno, S., Suschek, C. V., Heydthausen, M., Gabbert, H. E., & Gerharz, C. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600153 · Cited by 138
Fukuda, S., Foster, R. G., Porter, S. B., & Pelus, L. M. (2002) · Blood · doi:10.1182/blood.v100.7.2463 · Cited by 136
Sui, L., Dong, Y., Ohno, M., et al. (2002) · International Journal of Oncology · doi:10.3892/ijo.21.2.315 · Cited by 128
Survivin Loss in Thymocytes Triggers p53-mediated Growth Arrest and p53-independent Cell Death
Okada, H., Bakal, C., Shahinian, A., Elia, A., Wakeham, A. C., Suh, W., Duncan, G. S., Ciofani, M., Rottapel, R. K., Zúñiga‐Pflücker, J. C., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032092 · Cited by 128
cIAP1 Localizes to the Nuclear Compartment and Modulates the Cell Cycle
Samuel, T., Okada, K., Hyer, M. L., Welsh, K., Zapata, J. M., & Reed, J. C. (2005) · Cancer Research · doi:10.1158/0008-5472.210.65.1 · Cited by 115
Survivin does not inhibit caspase-3 activity
Banks, D. P., Plescia, J., Altieri, D. C., Chen, J., Rosenberg, S. H., Zhang, H., & Ng, S. (2000) · Blood · doi:10.1182/blood.v96.12.4002.h8004000c_4002_4003 · Cited by 114
Survivin-Dependent Angiogenesis in Ischemic Brain
Conway, E. M., Zwerts, F., Eygen, V. V., Vriese, A. D., Nagai, N., Luo, W., & Collen, D. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63453-0 · Cited by 102
Radiosensitization of Human Melanoma Cells by Ribozyme-Mediated Inhibition of Survivin Expression
Pennati, M., Binda, M., Colella, G., Folini, M., Villa, R., Daidone, M. G., Zaffaroni, N., & Citti, L. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12082.x · Cited by 97
Conway, E. M., Pollefeyt, S., Steiner‐Mosonyi, M., Luo, W., Vriese, A. D., Lupu, F., Bono, F., Leducq, N., Dol, F., Schaeffer, P., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34753 · Cited by 97
Survivin, bcl-2, bax, and bcl-X Gene Expression in Sentinel Lymph Nodes From Melanoma Patients
Gradilone, A., Gazzaniga, P., Ribuffo, D., Scarpa, S., Cigna, E., Vasaturo, F., Bottoni, U., INNOCENZI, D., Calvieri, S., Scuderi, N., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.066 · Cited by 97
Pennartz, S., Belvindrah, R., Tomiuk, S., Zimmer, C., Hofmann, K., Conradt, M., Bosio, A., & Cremer, H. (2004) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2003.12.011 · Cited by 86
Inhibition of survivin expression suppresses the growth of aggressive non-Hodgkin's lymphoma
Ansell, S. M., Arendt, B. K., Grote, D. M., Jelinek, D. F., Novak, A. J., Wellik, L. E., Remstein, E. D., Bennett, C. F., & Fielding, A. K. (2004) · Leukemia · doi:10.1038/sj.leu.2403281 · Cited by 84
Zhu, N., Gu, L., Findley, H. W., Li, F., & Zhou, M. (2004) · Oncogene · doi:10.1038/sj.onc.1208038 · Cited by 57
Allen, S., Florell, S. R., Hanks, A. N., Alexander, A., Diedrich, M. J., Altieri, D. C., & Grossman, D. (2003) · PubMed · Cited by 56
Wang, Z., Sampath, J., Fukuda, S., & Pelus, L. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0303 · Cited by 55
Nuclear expression of the antiapoptotic protein survivin in malignant melanoma
Ding, Y., Prieto, V. G., Zhang, P. S., Rosenthal, S. I., Smith, K. J., Skelton, H. G., & Diwan, A. H. (2006) · Cancer · doi:10.1002/cncr.21727 · Cited by 39
X-Linked Inhibitor of Apoptosis Antagonism: Strategies in Cancer Treatment
Cheung, H. H., LaCasse, E. C., & Korneluk, R. G. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0817 · Cited by 35
Holzscheiter, L., Biermann, J., Kotzsch, M., Prezas, P., Farthmann, J., Baretton, G. B., Luther, T., Tjan‐Heijnen, V. C. G., Talieri, M., Schmitt, M., et al. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2005.065599 · Cited by 23
Cited by
The inhibitors of apoptosis (IAPs) as cancer targets
Hunter, A. M., LaCasse, E. C., & Korneluk, R. G. (2007) · Apoptosis · doi:10.1007/s10495-007-0087-3 · Cited by 565
STAT3 as a target for inducing apoptosis in solid and hematological tumors
Al Zaid Siddiquee, K., & Turkson, J. (2008) · Cell Research · doi:10.1038/cr.2008.18 · Cited by 487
Srinivasula, S. M., & Ashwell, J. D. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.008 · Cited by 450
Survivin: A new target for anti-cancer therapy
Ryan, B. M., O’Donovan, N., & Duffy, M. J. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.05.003 · Cited by 379
Self-citationMowatt, G., Zhu, S., Kilonzo, M., Boachie, C., Fraser, C., Griffiths, T., N'Dow, J., Nabi, G., Cook, J., & Vale, L. (2010) · Health Technology Assessment · doi:10.3310/hta14040 · Cited by 313
Metadata
- Authors
- Duffy, M. J., O’Donovan, N., Brennan, D. J., Gallagher, W. M., & Ryan, B. M.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2007-04
- Volume
- 249
- Issue
- 1
- Pages
- 49-60
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2110224130
- Cited by
- 267
- References
- 80
- FWCI
- 9.22
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.